Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA BIOCON AUROBINDO PHARMA/
BIOCON
 
P/E (TTM) x 23.0 19.7 116.8% View Chart
P/BV x 2.4 1.8 132.0% View Chart
Dividend Yield % 0.3 0.6 48.5%  

Financials

 AUROBINDO PHARMA   BIOCON
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
BIOCON
Mar-23
AUROBINDO PHARMA/
BIOCON
5-Yr Chart
Click to enlarge
High Rs715388 184.3%   
Low Rs397192 207.4%   
Sales per share (Unadj.) Rs424.293.1 455.8%  
Earnings per share (Unadj.) Rs32.95.4 614.3%  
Cash flow per share (Unadj.) Rs54.114.6 370.1%  
Dividends per share (Unadj.) Rs3.001.50 200.0%  
Avg Dividend yield %0.50.5 104.2%  
Book value per share (Unadj.) Rs458.1146.5 312.6%  
Shares outstanding (eoy) m585.941,200.60 48.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.33.1 42.1%   
Avg P/E ratio x16.954.1 31.2%  
P/CF ratio (eoy) x10.319.8 51.8%  
Price / Book Value ratio x1.22.0 61.4%  
Dividend payout %9.128.0 32.6%   
Avg Mkt Cap Rs m325,753347,814 93.7%   
No. of employees `000NANA-   
Total wages/salary Rs m35,22321,810 161.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m248,554111,742 222.4%  
Other income Rs m2,9067,681 37.8%   
Total revenues Rs m251,460119,423 210.6%   
Gross profit Rs m37,07016,611 223.2%  
Depreciation Rs m12,44611,131 111.8%   
Interest Rs m1,4054,190 33.5%   
Profit before tax Rs m26,1258,971 291.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,8492,541 269.5%   
Profit after tax Rs m19,2776,430 299.8%  
Gross profit margin %14.914.9 100.3%  
Effective tax rate %26.228.3 92.5%   
Net profit margin %7.85.8 134.8%  
BALANCE SHEET DATA
Current assets Rs m214,599123,340 174.0%   
Current liabilities Rs m114,93885,107 135.1%   
Net working cap to sales %40.134.2 117.2%  
Current ratio x1.91.4 128.8%  
Inventory Days Days21129 16.0%  
Debtors Days Days66117 56.2%  
Net fixed assets Rs m176,668394,078 44.8%   
Share capital Rs m5866,003 9.8%   
"Free" reserves Rs m267,813169,926 157.6%   
Net worth Rs m268,399175,929 152.6%   
Long term debt Rs m6,190152,905 4.0%   
Total assets Rs m392,125517,418 75.8%  
Interest coverage x19.63.1 623.9%   
Debt to equity ratio x00.9 2.7%  
Sales to assets ratio x0.60.2 293.5%   
Return on assets %5.32.1 257.0%  
Return on equity %7.23.7 196.5%  
Return on capital %10.04.0 250.5%  
Exports to sales %33.73.1 1,085.4%   
Imports to sales %15.36.0 257.1%   
Exports (fob) Rs m83,7033,467 2,414.3%   
Imports (cif) Rs m38,0606,654 572.0%   
Fx inflow Rs m85,4833,467 2,465.6%   
Fx outflow Rs m41,4476,654 622.9%   
Net fx Rs m44,036-3,187 -1,381.7%   
CASH FLOW
From Operations Rs m23,86818,525 128.8%  
From Investments Rs m-39,778-142,818 27.9%  
From Financial Activity Rs m18,144130,487 13.9%  
Net Cashflow Rs m2,2986,411 35.8%  

Share Holding

Indian Promoters % 48.8 40.4 120.8%  
Foreign collaborators % 3.1 20.3 15.1%  
Indian inst/Mut Fund % 41.3 21.1 196.2%  
FIIs % 20.7 6.6 316.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 39.4 122.4%  
Shareholders   241,944 434,339 55.7%  
Pledged promoter(s) holding % 20.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Aurobindo Pharma vs Biocon

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs Biocon Share Price Performance

Period Aurobindo Pharma Biocon S&P BSE HEALTHCARE
1-Day 1.82% 2.92% 1.18%
1-Month 5.96% -2.53% -0.75%
1-Year 113.07% 30.52% 61.82%
3-Year CAGR 7.78% -13.55% 18.16%
5-Year CAGR 7.18% -2.73% 19.79%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the Biocon share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of Biocon the stake stands at 60.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of Biocon.

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 9.1%.

Biocon paid Rs 1.5, and its dividend payout ratio stood at 28.0%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of Biocon.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.